Profile
Gisela Mautner is currently a Member at The CEO Institute, Inc. and a Member at the Australia Institute of Co. Directors.
Former roles include Chief Executive Officer, MD & Director at Noxopharm Ltd. from 2022 to 2026, and Independent Non-Executive Director at Nyrada, Inc. from 2022 to 2025.
Education includes graduate studies at Harvard University, an MBA from Northwestern University, and a doctorate from Ludwig-Maximilians-Universität München.
Gisela Mautner active positions
| Companies | Position | Start |
|---|---|---|
Australia Institute of Co. Directors | Corporate Officer/Principal | - |
The CEO Institute, Inc.
The CEO Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Offers executive consulting services | Corporate Officer/Principal | - |
Former positions of Gisela Mautner
| Companies | Position | End |
|---|---|---|
| NOXOPHARM LIMITED | Chief Executive Officer | 2026-04-14 |
| NYRADA INC. | Director/Board Member | 2025-11-11 |
Training of Gisela Mautner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The CEO Institute, Inc.
The CEO Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Offers executive consulting services | Commercial Services |
Australia Institute of Co. Directors | |
Noxopharm Ltd.
Noxopharm Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer treatment | Health Technology |
Nyrada, Inc.
Nyrada, Inc. Pharmaceuticals: MajorHealth Technology Operates as pre-clinical stage drug development company, specializes in development of novel small molecule drugs | Health Technology |
- Stock Market
- Insiders
- Gisela Mautner
















